Luxa Biotechnology, LLC
1 clinical trials · Sponsor
◉ Watch Luxa Biotechnology, LLC
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) (NCT04627428) | Luxa Biotechnology, LLC | 2022-04-05 |
Track Luxa Biotechnology, LLC automatically
Every clearance here is in the API, with alerts when new ones post.